EGFR inhibits DNA mismatch repair

Proceedings of the National Academy of Sciences of the United States of America

Volumn 112, Issue 18, 2015, Pages 5556-5557

  Hsieh, Peggy ^a   Pearlman, Alexander H ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN; CYCLINE; DNA POLYMERASE; EPIDERMAL GROWTH FACTOR RECEPTOR; EXONUCLEASE; HISTONE H4; KARYOPHERIN BETA; PROTEIN MSH2; PROTEIN MSH6; PROTEIN MUTS; PROTEIN TYROSINE KINASE; T LYMPHOCYTE RECEPTOR; DNA;

AUTOPHOSPHORYLATION; CANCER CELL; CELL CYCLE S PHASE; CELL DIFFERENTIATION; CELL MEMBRANE; CELL MOTILITY; CELL PROLIFERATION; CONFORMATIONAL TRANSITION; DINUCLEOTIDE REPEAT; DNA REPLICATION; DNA SYNTHESIS; ENDOPLASMIC RETICULUM; ENDOSOME; GOLGI COMPLEX; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HISTONE PHOSPHORYLATION; HUMAN; INDEL MUTATION; LIGAND BINDING; MISMATCH REPAIR; MOLECULAR INTERACTION; NOTE; NUCLEAR PORE COMPLEX; NUCLEOTIDE BINDING SITE; PRIORITY JOURNAL; SPONTANEOUS MUTATION; BIOSYNTHESIS; METABOLISM; NEOPLASM;

DNA; DNA MISMATCH REPAIR; HUMANS; NEOPLASMS; PROLIFERATING CELL NUCLEAR ANTIGEN; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 84928911760     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1505168112     Document Type: Note

References (18)

1. Kunkel TA, Erie DA (2005) DNA mismatch repair. Annu Rev Biochem 74:681-710.
2. Hsieh P, Yamane K (2008) DNA mismatch repair: Molecular mechanism, cancer, and ageing. Mech Ageing Dev 129(7-8):391-407.
3. Jiricny J (2013) Postreplicative mismatch repair. Cold Spring Harb Perspect Biol 5(4):a012633.
4. Mailand N, Gibbs-Seymour I, Bekker-Jensen S (2013) Regulation of PCNA-protein interactions for genome stability. Nat Rev Mol Cell Biol 14(5):269-282.
5. Yarden Y, Pines G (2012) The ERBB network: At last, cancer therapy meets systems biology. Nat Rev Cancer 12(8):553-563.
6. Arteaga CL, Engelman JA (2014) ERBB receptors: From oncogene discovery to basic science to mechanism-based cancer therapeutics. Cancer Cell 25(3):282-303.
7. Brand TM, et al. (2013) Nuclear EGFR as a molecular target in cancer. Radiother Oncol 108(3):370-377.
8. Han W, Lo HW (2012) Landscape of EGFR signaling network in human cancers: Biology and therapeutic response in relation to receptor subcellular locations. Cancer Lett 318(2):124-134.
9. Wang SC, et al. (2006) Tyrosine phosphorylation controls PCNA function through protein stability. Nat Cell Biol 8(12):1359-1368.
10. Ortega J, et al. (2015) Phosphorylation of PCNA by EGFR inhibits mismatch repair and promotes misincorporation during DNA synthesis. Proc Natl Acad Sci USA 112:5667-5672.
11. Hewish M, Lord CJ, Martin SA, Cunningham D, Ashworth A (2010) Mismatch repair deficient colorectal cancer in the era of personalized treatment. Nat Rev Clin Oncol 7(4):197-208.
12. Peltomäki P (2014) Epigenetic mechanisms in the pathogenesis of Lynch syndrome. Clin Genet 85(5):403-412.
13. Guarné A, Charbonnier JB (2015) Insights from a decade of biophysical studies on MutL: Roles in strand discrimination and mismatch removal. Prog Biophys Mol Biol, 10.1016/j.pbiomolbio.2015.02.002.
14. Pluciennik A, et al. (2010) PCNA function in the activation and strand direction of MutLα endonuclease in mismatch repair. Proc Natl Acad Sci USA 107(37):16066-16071.
15. Goellner EM, et al. (2014) PCNA and Msh2-Msh6 activate an Mlh1-Pms1 endonuclease pathway required for Exo1-independent mismatch repair. Mol Cell 55(2):291-304.
16. Chou RH, et al. (2014) EGFR modulates DNA synthesis and repair through Tyr phosphorylation of histone H4. Dev Cell 30(2):224-237.
17. Dittmann K, et al. (2011) Nuclear epidermal growth factor receptor modulates cellular radio-sensitivity by regulation of chromatin access. Radiother Oncol 99(3):317-322.
18. Goh LK, Sorkin A (2013) Endocytosis of receptor tyrosine kinases. Cold Spring Harb Perspect Biol 5(5):a017459.